FDA Conditionally Approves First Drug for Anemia in Cats
Regulation
FDA Conditionally Approves First Drug for Anemia in Cats
2023-05-01 21:28:01
by Dan McCue

WASHINGTON — The Food and Drug Administration on Monday conditionally approved Varenzin-CA1, the first drug for the control of nonregenerative anemia associated with chronic kidney disease in cats.  Nonregenerative anemia is a potentially fatal condition in which a cat’s bone... Read More

NIH-Funded Study Identifies New, More Effective Approach to Treating Cat Allergies
Health
NIH-Funded Study Identifies New, More Effective Approach to Treating Cat Allergies
2022-10-14 15:39:52
by Dan McCue

BETHESDA, Md. — An experimental approach to enhancing a standard cat allergy treatment made it more effective and faster acting, and the benefits persisted for a year after treatment ended, a study supported by the National Institutes of Health has... Read More

Straight From The Well
scroll top